Breaking News

Covectra Gains GS1 EPCglobal Certification

By Kristin Brooks | February 5, 2014

AuthentiTrack serialization database and repository meet supply chain standards

Covectra, a serialization, authentication, and track and trace technology provider, has been granted GS1 EPCglobal Drug Pedigree certification. The company is now actively involved in compliance projects in the U.S., Europe, and China using this standard. Covectra will provide services for various pharmaceutical, medical device, and specialty food customers, utilizing custom serialization solutions aimed at driving supply chain security.
Covectra was awarded the GS1 EPCglobal Drug Pedigree for its AuthentiTrack serialization database and event repository after completing all the mandatory testing. EPCglobal, part of the not-for-profit supply chain standards organization GS1, is dedicated to driving the adoption of the Electronic Product Code (EPC) for supply chain excellence.
“Although the deadlines for the Drug Quality Security Act (H.R. 3204) become mandated incrementally from 2017 until 2023, many companies are recognizing that investing in technology and adhering to compliance now provides a variety of benefits. Those include improvements in supply chain efficiencies and control, as well as brand/product integrity, which all are based on serialization numbers and a system developed in accordance with GSI EPC Drug Pedigree standards,” said Steve Wood, president and chief executive officer of Covectra. “We are helping companies get ahead of the curve, while taking advantage of a variety of business benefits that can be achieved with serialization in addition to regulatory compliance. We are proud to be one of the few companies that is both EPCIS and Drug Pedigree Certified in our current markets.”

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks